Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact

By V. Aloush, S. Navon-Venezia, Yardena Seigman-Igra, S. Cabili, Yehuda Carmeli. Antimicrobial Agents and Chemotherapy, 2006

657 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/67eba1d98ba90b5216d53e3eb6e821c5f21892ff

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Medicine

1. P. Plésiat
2. P. Nordmann
3. L. Poirel
4. K. Bush
5. P. Bradford

In Pharmacology

1. P. Nordmann

Citations in the corpus

• Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. (2007, background): “These isolates combine several mechanisms of resistance, often present on mobile genetic elements, and are usually associated with severe adverse clinical outcomes [21,48,67].”
• Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms (2009, background): “aeruginosa are associated with significant increases in morbidity, mortality, need for surgical intervention, length of hospital stay and chronic care, and overall cost of treating the infection (7, 25, 62).”